Giulia Bortolussi è un Ricercatore Associato all’ICGEB di Trieste. Ha ottenuto una laurea in Biologia Molecolare ed un Dottorato di Ricerca in Scienze biomolecolari all’Università di Trieste. Giulia ha un’esperienza di oltre 15 anni nel campo della bilirubina, spaziando dallo studio dell’ittero neonatale alla Sindrome di Crigler-Najjar. Questi studi l’hanno condotta allo sviluppo di approcci terapeutici volti a ridurre/prevenire il danno neurologico indotto da bilirubina, così come alla sperimentazione di terapie innovative per la cura dei disordini metabolici ereditari epatici quali la terapia genica e l’editing genetico
Giulia Bortolussi
researcher ICGEB
Giulia Bortolussi is a Research Associate at ICGEB Trieste. She holds a degree in Molecular Biology and a PhD in Biomolecular Sciences from the University of Trieste. She has more than 15 years of experience in the field of bilirubin, ranging from neonatal hyperbilirubinemia to Crigler-Najjar Syndrome. This led her to the study and development of therapeutic approaches aiming to reduce neurological damage induced by bilirubin as well as advanced gene therapy and genome editing methodologies for treating inherited metabolic diseases of the liver.
Friday 27 september / time 16.30-17.45
Palazzo Gopcevich, Sala Bazlen
Palazzo Gopcevich, Via Gioacchino Rossini, Trieste, TS, ItaliaPalazzo Gopcevich, Sala Bazlen
A panel with
Giulia Bortolussi, researcher ICGEB
Nicola Brunetti-Pierri, principal investigator Telethon Institute of Genetics and Medicine, professor of Pediatrics at Federico II University of Naples
Federico Mingozzi, Chief Executive a stealth Company
Andrés Muro, group leader Mouse Molecular Genetics Laboratory ICGEB
Chaired by
Laura Celotto, communications office ICGEB
The event will take place in italian